Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide

被引:198
作者
Zhang, Y [1 ]
Permar, S [1 ]
Sun, ZH [1 ]
机构
[1] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
关键词
D O I
10.1099/0022-1317-51-1-42
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pyrazinamide (PZA) is an important front-line anti-tuberculosis drug that is active only at acid pH. However, acid pH causes significant difficulty for PZA susceptibility testing. A common problem in PZA testing is false resistance caused by large bacterial inocula. This study investigated the relationship of false resistance to numbers of bacilli, pit and other factors that potentially affect susceptibility to PZA. Large inocula (1014 bacilli/ml) of M. tuberculosis H37Ra caused significant increase in medium pit from 5.5 towards neutrality, and thus produced false resistance results. The increase in medium pH was determined to be a function of live bacilli; heat-killed bacilli had little or no effect. Susceptibility to PZA and its active derivative pyrazinoic acid (POA) was comparable on 7H11 agar medium, but POA was less active than PZA in liquid medium containing bovine serum albumin (BSA), suggesting that susceptibility to PZA or POA was reduced in the presence of BSA, because of its neutralising effect on medium pit and significant POA binding. A 3-month-old H37Ra culture was shown to be more susceptible to PZA exposure than a 4-day log-phase culture, suggesting that PZA is more active for non-growing bacilli. Finally, reserpine, an inhibitor of POA efflux pump, increased susceptibility to PZA even near neutral pH 6.8, with an MIC of 400 mg/L compared with 1000 mg/L without reserpine. These findings should have implications for understanding the mode of action of PZA and for PZA susceptibility testing.
引用
收藏
页码:42 / 49
页数:8
相关论文
共 30 条
[1]  
Allen BW, 1998, METH MOL B, V101, P15, DOI 10.1385/0-89603-471-2:15
[2]  
BONICKE R, 1959, TUBERKULOSEARZT, V13, P375
[3]  
Budavari S., 1989, The merck index: an encyclopedia of chemicals, drug, and biologicals
[4]   pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis:: Spread of a monoresistant strain in Quebec, Canada [J].
Cheng, SJ ;
Thibert, L ;
Sanchez, T ;
Heifets, L ;
Zhang, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :528-532
[5]  
DICKINSON J M, 1970, Tubercle, V51, P389
[6]   PYRAZINAMIDE STERILIZING ACTIVITY INVITRO AGAINST SEMIDORMANT MYCOBACTERIUM-TUBERCULOSIS BACTERIAL-POPULATIONS [J].
HEIFETS, L ;
LINDHOLMLEVY, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (05) :1223-1225
[7]   New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide [J].
Heifets, L ;
Sanchez, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) :1498-1501
[8]   DOES PYRAZINOIC ACID AS AN ACTIVE MOIETY OF PYRAZINAMIDE HAVE SPECIFIC ACTIVITY AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
HEIFETS, LB ;
FLORY, MA ;
LINDHOLMLEVY, PJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1252-1254
[9]   DRUG-RESISTANT TUBERCULOSIS - INCONSISTENT RESULTS OF PYRAZINAMIDE SUSCEPTIBILITY TESTING [J].
HEWLETT, D ;
HORN, DL ;
ALFALLA, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :916-917
[10]   Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis [J].
Hirano, K ;
Takahashi, M ;
Kazumi, Y ;
Fukasawa, Y ;
Abe, C .
TUBERCLE AND LUNG DISEASE, 1998, 78 (02) :117-122